Detalhe da pesquisa
1.
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Breast Cancer Res
; 19(1): 7, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28095868